AF

#ESC2020 RATE-AF Digoxin v Bisoprolol for rate control

#ESC2020 RATE-AF Digoxin v Bisoprolol for rate control

Asif Qasim
   
Digoxin improved some measures of quality of life at 12 months and was associated with greater reductions in NYHA class and NT-proBNP. Digoxin was also associated with fewer adverse events compared with beta-blockers.